Vanguard Fiduciary Trust
MIRM icon

Vanguard Fiduciary Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8M Buy
348,230
+14,903
+4% +$1.5M 0.01% 975
2026
Q1 		$30.8M Buy
+333,327
New +$31.4M 0.01% 1061

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's MIRM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Mirum Pharmaceuticals (MIRM) stake by 4.5% in Q2 2026, buying an estimated $1.5M and bringing the position to 348,230 shares worth $40.8M. The position accounts for 0.01% of the portfolio, ranked #975.

Vanguard Fiduciary Trust first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Vanguard Fiduciary Trust held 348,230 shares of Mirum Pharmaceuticals worth $40.8M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 14,903 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.5M.
  • Mirum Pharmaceuticals made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #975 holding.
  • Vanguard Fiduciary Trust first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 326 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.